Sol-Gel Technologies Ltd. Ordinary Shares (SLGL) is a publicly traded Healthcare sector company. As of May 21, 2026, SLGL trades at $65.92 with a market cap of $221.81M and a P/E ratio of 0.00. SLGL moved +0.00% today. Year to date, SLGL is +47.75%; over the trailing twelve months it is +746.27%. Its 52-week range spans $4.01 to $97.97. Analyst consensus is buy with an average price target of $184.00. Rallies surfaces SLGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sol-Gel Raises $33.1M via Oversubscribed $72 Share Offering: Sol-Gel priced 459,112 new shares at $72 each, raising about $33.1 million in an oversubscribed underwritten offering expected to close March 25, 2026. Net proceeds will fund Phase 3 development and pre-commercialization of SGT-610 and support general corporate and working capital needs.
| Metric | Value |
|---|---|
| Price | $65.92 |
| Market Cap | $221.81M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $97.97 |
| 52-Week Low | $4.01 |
| Volume | 16 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover SLGL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $184.00.